(TB) eradication has now become a global plight. New disease prevention and treatment issues are being raised due to prevalence of increased drug resistance and synergistic interactions with other immune ailments like HIV and diabetes mellitus. The TB infection is an outcome of the poor immune status and is quite often described as poverty-related disease, linked with financial deprivation and social marginalization. This hints towards the crucial requirement of a healthy lifestyle and nutritious food for its prevention and cure. As microbes around us are evolving smartly, a bottom up approach concomitantly targeting host factors would be a better combinatorial course towards controlling TB prevalence and mortality. Therefore, the current study focuses on three nuclear receptors (NRs) :
vitamin D receptor (VDR), liver X receptor (LXR) and rev-erb alpha (Reverbα) and comprises of a design that evaluates the chemotherapeutic efficacy of anti-tubercular drugs, alone or in different synergistic combinations with the ligands of contextually relevant nuclear receptors at their therapeutic dose.
Methods:
The concluding results were attained by employment of bacterial viability assay.
Results: Besides leading to better M. tuberculosis clearance, viability assays showed that treatment with combination of these NRs ligands proved beneficial in reducing dosage of drugs and duration of treatment in-vitro.
Conclusion:
Since these NRs can be targeted via nutrition, the combinatorial therapy involving amalgam of VDR, Rev-erbα and LXR ligands as a dietary supplement might prove helpful in reducing dosage or duration of present TB treatment. Moreover, the nutritional cocktail would be risk-free for HIV/diabetic patients harbouring TB infection as these NRs possess anti-diabetic and anti-viral effects. In a peroration, strengthening host body for the battle against TB would lead to improving the cure outcomes and minimizing the relapse rates. 258-856 cells/cu.mm. In this case report, we present an HIV-negative patient with miliary TB and profound CD4 lymphopenia.
Methods:
We have a previously healthy 34-year-old male, who came in acute respiratory failure. Patient presented with progressive dyspnea with fever, diarrhoea, weakness, oral sores and weight loss. Initial workup revealed miliary TB on chest CT scan, candida growth on sputum culture, markedly elevated lactate dehydrogenase (LDH) and positive Sputum PCR for tuberculosis.
Results: Patient was managed as a case of severe pneumonia, miliary tuberculosis, fungal pneumonia, and was given Cefepime, Metronidazole, Levofloxacin, Fluconazole and quadruple antituberculosis medications. Despite treatment, he was persistently tachypneic with hypoxemia on non-invasive ventilatory support. Despite a negative sputum PCR for Pneumocystic jiroveci, Cotrimoxazole and Hydrocortisone were started, which improved patient's condition. CD4+ T cell count was 55 cells/cu.mm and HIV test was negative. On follow-up, he was symptom-free and has gained weight. Repeat HIV testing at 3 and 6 months turned out to be negative. Repeat CD4+ T cell count after completion of anti-tuberculosis medications increased to 277 cells/cu.mm.
Conclusion:
Tuberculosis, especially the disseminated type, can cause profound lymphopenia, mimicking the effects of HIV. CD4 lymphopenia may cause opportunistic infections, as seen in patients with AIDS. It is important to realize the such effect can be seen also in military TB. Adequate treatment and close follow-up is important to rule out primary CD4 lymphopenia. Background and Aims: Japan has the longest life expectancy in the world and is the only developed country with a middle burden of tuberculosis. While advanced age has been suggested to be a prognostic factor in patients with tuberculosis, the characteristics that are associated with poor outcomes among elderly patients remain unclear. The aim of this study was to assess the prognostic factors among elderly patients admitted to a hospital for lung tuberculosis. 
